## CLX: The Clorox Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -4.3% below STRENGTH zone (4.0-10.0%); PEG 3.19 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (59% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($94.39)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Is the Options Market Predicting a Spike in The Clorox Stock?**
- Source: TradingView â€” Track All Markets | 20251226T180755 | Neutral | Relevance: 100%
- The options market is showing high implied volatility for The Clorox Company (CLX), particularly for its Jan. 16, 2025 $75 Call, suggesting expectations of a significant price movement. Despite this, analysts currently rate Clorox as a Zacks Rank #3 (Hold) with a recent slight decrease in earnings estimates, indicating a potential trading opportunity for those who sell premium.

**2. Clorox (CLX) Valuation Check as Mixed Analyst Views Meet Operational Improvements and Innovation Hopes**
- Source: Simply Wall Street | 20251225T053653 | Somewhat-Bullish | Relevance: 100%
- Clorox (CLX) is currently undervalued based on Simply Wall St's analysis, with an intrinsic value significantly above its recent closing price. Despite a sharp decline in share price this year, operational improvements, such as the implementation of a modern ERP system, and innovation efforts are expected to drive long-term efficiencies and margin expansion. However, sluggish category growth and heightened competition pose potential risks to the company's earnings recovery.

**3. The Clorox Company $CLX Shares Bought by Brookstone Capital Management**
- Source: MarketBeat | 20251226T085104 | Neutral | Relevance: 100%
- Brookstone Capital Management significantly increased its stake in The Clorox Company ($CLX) by 1,395.4% during the third quarter, acquiring 88,024 additional shares to hold a total of 94,332 shares valued at approximately $11.63 million. This strategic move makes Brookstone Capital Management a notable institutional investor in Clorox, owning 0.08% of the company's stock. The article also highlights that analysts generally have a "Reduce" rating on CLX with a consensus price target of $125.00, and Clorox recently declared a quarterly dividend of $1.24 per share, offering an annualized yield of 5.1%.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $109 | $120 | -9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($10.20M) |
| Sells | 11 ($0.63M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.7%)
- Blackrock Inc.: 8.5% (-1.2%)
- State Street Corpora: 6.9% (+3.5%)
- Invesco Ltd.: 3.3% (+23.1%)
- Morgan Stanley: 2.6% (+18.3%)

### Key Risks

1. Valuation stretched: PEG 3.2x requires aggressive growth execution.
2. Long-term trend broken: trading 20.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.19 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 44%, ROA 12%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($10.2M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.0B |
| Beta | 0.57 |
| 52W Range | $96.66 - $164.41 |
| Short Interest | 6.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.19 |
| Forward P/E | 14.6 |
| Current P/E | 16.5 |
| YoY Growth | 12.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -5.4% to -4.3% (+1.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 8.3pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.0%) - potential reversal signal. AM_20 at -3.4% indicates price below own 20MA trend. Underperforming sector by 3.4pp, stock-specific weakness. Below SMA200 (0.80x), long-term trend not supportive. Volume at 59% of 20MA suggests lack of conviction. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.30% (CS: 12) | Weak |
| RSI_14 | 36.9 | Neutral |
| MACD Histogram | -0.14 | Bearish |
| vs SMA20 | 0.966x | Below |
| vs SMA50 | 0.926x | Below |
| vs SMA200 | 0.796x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $98.53
- **Stop Loss:** $94.39 (4.2% risk)
- **Target:** $102.67 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 132
- **Position Value:** $13,005.96
- **Portfolio %:** 13.01%
- **Risk Dollars:** $550.00
- **Risk Per Trade:** 0.55%
- **Modifiers:** L1 110% | L2 50% | Combined 0.55x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-03 (Est: $1.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.78 | $0.85 | +9.2% |
| 2025Q2 | $2.21 | $2.87 | +29.8% |
| 2025Q1 | $1.56 | $1.45 | -6.9% |
| 2024Q4 | $1.40 | $1.55 | +10.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*